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Abstract
The degree to which gene expression covaries between different primary tissues within an individual is not well defined. We
hypothesized that expression that is concordant across tissues is more likely influenced by genetic variability than gene
expression which is discordant between tissues. We quantified expression of 11,873 genes in paired samples of primary
leukemia cells and normal leukocytes from 92 patients with acute lymphoblastic leukemia (ALL). Genetic variation at
.500,000 single nucleotide polymorphisms (SNPs) was also assessed. The expression of only 176/11,783 (1.5%) genes was
correlated (p,0.008, FDR=25%) in the two tissue types, but expression of a high proportion (20 of these 176 genes) was
significantly related to cis-SNP genotypes (adjusted p,0.05). In an independent set of 134 patients with ALL, 14 of these 20
genes were validated as having expression related to cis-SNPs, as were 9 of 20 genes in a second validation set of HapMap
cell lines. Genes whose expression was concordant among tissue types were more likely to be associated with germline cis-
SNPs than genes with discordant expression in these tissues; genes affected were involved in housekeeping functions
(GSTM2, GAPDH and NCOR1) and purine metabolism.
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Introduction
The influence of germline genetic variation on global gene
expression in health[1–5]and disease[6–8] is an area of considerable
interest. A number of recent studies have focused on the influence of
germline variability in ‘‘normal’’ lymphoblastoid cell lines through
association and linkage studies[9–13]. A considerable proportion of
inter-individual differences in gene expression is likely due to germline
variability produced by single nucleotide polymorphisms (SNPs).
These SNPs may act by cis or by trans mechanisms[9,11,13,14],
althoughcis-regulatoryvariationappearstobemorereadilydetectable
than trans, with lower false positive findings[11,14,15]. Prior studies
have focused on normal hematopoietic tissues and the majority are
limited to the HapMap EBV-transformed lymphoblastoid cell lines
instead of primary tissues. However, there are limited data indicating
that in the absence of disease, leukocyte gene expression displays less
variability within an individual than it does between individuals;
differences partly attributable to gender and ethnicity[15–17]. A
component of this invariant expression is produced by a subset of the
genome comprising ‘‘housekeeping genes’’ that are continuously and
ubiquitously expressed across multiple tissues and are likely essential
for normal cellular function[18–21]. How germline polymorphisms in
these housekeeping genes affect gene expression in multiple tissue
types remains largely unexplored.
Tumor tissue gene expression is influenced not only by germline
but also by somatically-acquired genomic variability. Inter-individ-
ual differences in gene expression within any given tumor type have
been successfully used to refine tumor subtype classification and to
identify genes associated with drug resistance and treatment
outcome[22–25]. Although it is clear that some of the inter-
individual variation in tumor tissue is due to somatically acquired
changes specific to the cancer genome, it is not known to what
extent this variation is influenced by differences in allele frequencies
in germline polymorphisms among individuals. Herein we quanti-
fied gene expression from 92 patients with acute lymphoblastic
leukemia (ALL) in paired normal and cancer tissues to assess the
concordance of gene expression in these tissues, and the relationship
between germline genomic variation and gene expression. Geno-
type-phenotype relationships were confirmed in an independent
group of 134 patients with newly diagnosed ALL, and in the CEU
and YRI populations of the HapMap cell lines (Figure 1).
Results
Gene expression that covaries in leukemia and normal
cell primary tissues
We assessed gene expression for 11,783 genes in paired
diagnostic leukemia cells and normal leukocytes (collected 8 weeks
PLoS ONE | www.plosone.org 1 May 2008 | Volume 3 | Issue 5 | e2144later) from 92 patients with newly diagnosed acute lymphoblastic
leukemia (ALL). Unsupervised hierarchical clustering of gene
expression produced two major groupings: diagnostic leukemia
cells and normal leukocytes formed two discrete clusters (Figure
S1), with 58% of the genes exhibiting discordance in gene
expression (p,0.001) between the two primary tissue types.
Within the diagnostic leukemia cell samples, clustering by
leukemia subtype was observed, as we have previously de-
scribed[22,23]. The normal leukocyte samples did not segregate
into any well-defined clusters based upon demographic factors (i.e.
sex, race, and age).
The expression of 176 genes was significantly positively
correlated between diagnostic leukemia cells and normal leukocyte
samples (p,0.008), with a false discovery rate (FDR) of 25%
(Table S1; Figures S2 and S3). There was no significant difference
in the average expression levels of these 176 genes between the two
tissues (p=0.79, paired t-test).
Genome-wide assessment of genotypes associated with
concordant gene expression in leukemia cells and
normal leukocytes (the discovery set)
Of the 92 paired samples in the discovery set, 82 had germline
genotypes available from a genome-wide scan of .500,000 SNPs.
SNPs were evaluated for their influence on gene expression in both
diagnostic leukemia cells and normal leukocytes independently,
and these cis-SNPs that predicted gene expression in both
leukemia cells and normal leukocytes were further examined.
Genes whose expression was significantly positively correlated
(p,0.008) between diagnostic leukemia cells and normal leuko-
cytes were more likely (p=3.71610
218, Fishers exact test) to have
cis-SNPs (within 50 Kb of a gene interrogated on the gene
expression array used) whose allele frequency was significantly
associated with gene expression than genes whose expression was
discordant in leukemia cells and normal leukocytes (Figure 2).
Specifically, only 53 of 8,853 (0.60%) commonly expressed genes
(affected by 150 cis-SNPs) had cis-SNP genotypes that significantly
predicted (adjusted p,0.05) gene expression in both diagnostic
leukemia cell and normal leukocyte samples, compared to 20 of
176 (11.4%) genes (affected by 86 cis-SNPs) whose expression
positively correlated (p,0.008) between diagnostic leukemia cells
and normal leukocytes (Table 1; Figures 2, 3 and 4; Figure S4). We
observed no difference in the number of genes with cis-SNPs
associated with gene expression of the concordantly expressed
genes between the leukemia cells (n=30 genes) and the normal
leukocytes (n=30 genes) (Figure 2a). Of these 20 genes, the cis-
SNPs associated with their expression found within the same gene
were in high linkage disequilibrium (LD), but the SNPs associated
with different genes were not in LD. There was no significant
difference in the level of expression of these 20 genes between the
two tissues (p=0.49, paired t-test). The average expression level of
these 20 genes was higher than the overall expression level of the
176 genes: only one out of the 20 genes (5%) had a gene expression
level less than 8 in both tissues, compared to 58 genes out of the
remaining 156 genes that correlated between tissue types (37%,
Figure 1. The overall strategy: Left: determination of genes whose expression is concordant between diagnostic leukemia cells and
normal leukocytes; here the expression of CTSW is depicted as an example. Middle: discovery of germline cis-SNPs that are significantly
related to the level of expression of such concordant genes; here a cis-SNP genotype is related to the expression of an example gene (CTSW). Right:
validation of the relationship between these same cis-SNPs and their genes in two independent validation sets; here the same cis-SNP related to the
expression of CTSW.
doi:10.1371/journal.pone.0002144.g001
cis-SNPs Determine Expression
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transcripts that did not correlate between tissues (Figure S2).
Additionally, a relatively high percentage of the observed variation
in the expression of these 20 genes was attributed to the cis-SNPs,
approximately 26% (range=8–58%) in the leukemia cells and,
34% (range=14–64%) in the normal leukocytes.
Validation of association between gene expression and
genotype
Validation set 1 consisted of an independent association analysis
between diagnostic leukemia cell gene expression and germline
SNPs from a separate group of 134 patients with newly diagnosed
ALL. Amongst the 20 genes whose expression correlated in
diagnostic leukemia cell and normal leukocyte paired samples and
whose expression was associated with cis-SNP genotypes in the
discovery set, 14 retained a significant cis-SNP association in
validation set 1 (adjusted p,0.05) (Table 1; Figure 2a and Figure 4).
Validation in set 2 consisted of an independent association
analysis between publicly available SNP and gene expression data
from the 60 CEU and 60 YRI individuals that constitute the core
unrelated members of the HapMap lymphoblastoid cell lines. Of
the 20 concordantly expressed genes in the discovery set whose
expression was associated with cis-SNP genotypes, all 20 were
interrogated on the Affymetrix Exon Array (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE7761), and the expression
of 8 were also significantly associated with cis-SNP genotypes
(Figure S5a); all 20 genes were also interrogated on the Illumina
BeadChip array (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE6536), and the expression of 9 were significantly
associated with cis-SNP genotypes in validation set 2 (adjusted
p,0.05) (Table 1; Figure 4). Thus, in two independent data sets, a
high proportion of cis-SNPs associated with concordant gene
expression in the discovery set were validated as also associating
with gene expression in two independent data sets: the HapMap
cell lines and another group of primary ALL blasts.
Genes of interest
The 204 probe sets (Table S1) with expression positively
correlating between diagnostic leukemia cells and normal
leukocytes represent 176 distinct genes with diverse cellular
functions. Several genes have important functions in system-wide
homeostasis (e.g. GSTM2 and GAPDH), while others are involved
in protein synthesis (e.g. RPS12, RPS4Y1 and RPL36AL)o ri n
purine metabolism (e.g. GART, XDH, CANT1 and ADSS). Seven of
these 176 genes overlap with those identified in the analysis of
Whitney AR et al. that reported genes that show large inter-
individual variation in expression in whole blood, including genes
involved in RNA regulation (DDX17), nuclear protein import
(KPNA6), and lymphocyte biology (HLA-DQA1, CTSW, and
GNLY)[26]. The expression of DDX17 was also shown to have
strong evidence of a cis-acting transcriptional regulator in the
analysis of Morley et al. using the CEU cell lines[9].
We found that a high percentage of genes (31/176 genes (18%))
whose expression correlated between paired tissue samples were
Figure 2. a) At adjusted p,0.05, there was no difference in the number of cis-SNPs associated with the expression of the concordant genes in the
normal leukocytes and the leukemia cells in the discovery set. In the discovery set of normal leukocytes (yellow circle), there are 30 out of 176 genes
that have significant cis-SNPs and in the discovery set of leukemia cells (green circle) there are 30 out of 176 genes that have significant cis-SNPs.
Additionally, in the validation set of leukemia cells (blue circle) there are 28 out of 176 genes that have significant cis-SNPs. There are 14 out of 176
genes with significant cis-SNPs that are common to all 3 of the populations representing 7.95%
* of the 176 genes. b) At adjusted p,0.05, there was
no difference in the number of cis-SNPs associated with the expression of all 8853 expressed genes in the normal leukocytes and the leukemia cells in
the discovery set. In the discovery set of normal leukocytes (yellow circle), there are 559 genes with significant cis-SNPs and in the discovery set of
leukemia cells (green circle), there are 532 genes that have significant cis-SNPs (p=0.41, Fishers exact test). Additionally, in the validation set of
leukemia cells (blue circle), there are 619 genes that have significant cis-SNPs. There are 28 out of 8853 genes with significant cis-SNPs that are
common to all 3 populations representing 0.32%
* of the 8853 genes.
doi:10.1371/journal.pone.0002144.g002
cis-SNPs Determine Expression
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and NCOR1) that were previously found to be expressed across
multiple tissues[20]. This is a much higher percentage compared
to the overall reported percentage of ‘‘housekeeping genes’’ among
all sampled genes (1789/22,685 or 0.7%) (p=0.0001) (Table S2).
Additionally, 5 of these ‘‘housekeeping genes’’ (CIB1, CSTB,
CTBP1, DDX17 and WARS) had cis-SNPs associated with their
expression.
Among the 176 genes whose expression was concordant
between the diagnostic leukemia cells and normal leukocytes,
Figure 3. a) An example of one of the 176 genes (here LRAP) whose expression was concordant between diagnostic leukemia cells and normal
leukocytes: Left: expression levels among 92 patients in leukemia cells and normal leukocytes are correlated (p=1.11610
214); Middle: expression of
this gene (median, quartiles, range) in leukemia cells is associated (adjusted p=0.0016) with the germline genotype of a particular cis-SNP in this
gene; Right: expression of this gene in normal leukocytes is also associated (adjusted p=0.0016) with the germline genotype at the same cis-SNP.
(See Figure S4 for additional examples.) b) An example of one of the 8853 genes (here DST) whose expression was not concordant between
diagnostic leukemia cells and normal leukocytes: Left: expression levels among 92 patients in leukemia cells and normal leukocytes are not correlated
(p=0.9384); Middle: expression of this gene in leukemia cells is not associated (adjusted p=1.0000) with the germline genotype of a particular cis-
SNP in this gene; Right: expression of this gene in normal leukocytes is also not associated (adjusted p=0.9994) with the germline genotype at the
same cis-SNP. (See Figure S4 for additional examples.)
doi:10.1371/journal.pone.0002144.g003
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Database for Annotation, Visualization and Integrated Discovery
(DAVID; http://david.abcc.ncifcrf.gov). These 157 genes are
overrepresented in pathways involving antigen processing and
presentation, cellular adhesion and ribosome function relative to
all of the genes investigated on the Affymetrix HG-U133A ArrayH
(Figure 5). Additional analysis of biological pathways of these 176
genes is provided in the Supporting Material (Figures S6 and S7).
Sequence motifs for cis-SNPs
We queried the 100 bp flanking regions of the 86 cis-SNPs
associated with the expression of the 20 genes whose expression
was concordant between tissues using MEME and found 3
common motifs (Table S3). We then searched for these motifs
among the 939 cis-SNPs associated with the expression of 532
genes in diagnostic leukemia cells (see Figure 2b, green circle), and
the 1072 cis-SNPs associated with the expression of 559 genes in
normal leukocyte samples (see Figure 2b, yellow circle). We found
that the three motifs were significantly overrepresented in the 86
cis-SNP sequences compared to the other sequences (Table S3),
however, these motifs are not known transcription factor binding
sites, consistent with the fact that we found no pairs of genes with a
significant correlation in expression in both the leukemia cells and
the normal leukocytes (p,0.05, Pearson’s correlation) (Figure S8
and Figure S9 respectively).
Discussion
Although global gene expression has been related to germline
genetic variation, this relationship has been based on associations
between genotype and gene expression in a single tissue type
sampled across multiple individuals. Herein we have identified a
set of genes with concordant expression in two independent tissue
types, leukemia cells and normal leukocytes, from the same
individuals. We hypothesized that genes whose expression
correlated in two independent tissues would be more likely to
exhibit gene expression variation related to germline SNP
genotypes than genes whose expression diverged between tissues.
We indeed observed that genes with concordant gene expression
in two tissue types were more likely to exhibit gene expression
variation that was influenced by cis-germline genotype variation in
primary tissue (discovery set), and these same cis-SNPs were
associated with gene expression variation in two independent data
sets, one comprising leukemia cells and one comprising non-
malignant lymphoblastoid cell lines (Figure 4).
The significant biological differences between leukemia cells and
normal peripheral blood leukocytes represent a rigorous setting in
which to uncover such cis genetic regulation. Commonalities in
gene expression and the underlying regulation of this expression in
two different tissues (one with additional somatically acquired
genetic defects, namely the leukemia cells) would be expected to be
difficult to detect. The fact that we detected genes whose
expression was concordant between tissue types that had strong
evidence of cis-regulation, and that such cis-regulation was
validated in two independent data sets, lends credence to our
findings. To our knowledge, this is the largest group of individuals
studied for genome-wide SNPs and genome-wide gene expression
in two independent tissues.
Germline polymorphisms have long been associated with
toxicity and outcome in cancer patients[27–29], but little has
been reported about the possible effect of these polymorphisms on
phenotypic variation in gene expression. Using a candidate gene
approach, we have shown previously that germline copy number
polymorphisms (in GSTM1, TYMS, and UGT1A1) were signifi-
cantly associated with leukemia cell gene expression in patients
with acute lymphoblastic leukemia, with the former two
polymorphisms also being associated with risk of ALL re-
lapse[29,30]. The results from the genome-wide approach herein
corroborate that germline SNP polymorphisms can also affect
global gene expression profiles, in both leukemia cells and normal
leukocytes. Our findings were validated in two independent
validation sets, the first using 134 pediatric ALL diagnostic
Figure 4. The 176 genes (open bars) whose expression was
concordant between diagnostic leukemia cells and normal
leukocytes were more likely (p=3.71610
218, Fishers exact test)
to have cis-SNP genotypes (within 50 Kb of a gene) associated
with their gene expression (20/176) than genes (closed bars)
whose expression was discordant between the leukemia cells
and normal leukocytes (53/8,853). A high proportion of these 176
genes whose expression was concordant between diagnostic leukemia
cells and normal leukocytes in the discovery set also had cis-SNPs
affecting gene expression in validation set 1 consisting of leukemia cells
(14/20) and in validation set 2 consisting of HapMap lymphoid cell lines
(9/20).
doi:10.1371/journal.pone.0002144.g004
Figure 5. Genes whose expression is significantly associated
between two tissue types (diagnostic leukemia cell and normal
leukocytes) are overrepresented in specific pathways relative
to all genes interrogated on the U133A microarray chip.
doi:10.1371/journal.pone.0002144.g005
cis-SNPs Determine Expression
PLoS ONE | www.plosone.org 6 May 2008 | Volume 3 | Issue 5 | e2144leukemia cell samples, the second using publicly available CEU
and YRI lymphoblastoid cell line data.
We acknowledge that in both the patient and cell line validation
sets, there are many more genes whose expression is significantly
associated with cis-SNPs. However, our goal here was to determine
if the cis-SNPs found to be associated with the concordant
expression of genes in two independent tissues from the same
individual could be replicated in other data sets, and we found this
to be true.
The genes we found that correlated within an individual
between diverse tissues had noteworthy overlap with genes whose
expression predicted variation between individuals previous-
ly[2,3,26]. Prior studies have focused on elucidating genes whose
expression differs both between individuals and within the same
individual, using the same tissue type. In normal peripheral blood
leukocytes[2,3] and in whole blood[26], inter-individual gene
expression variation was larger than intra-individual variation at
multiple time points. Many of these genes are ‘‘housekeeping
genes,’’ which could plausibly be expected to be expressed
similarly across multiple tissues[20]. Genes that are members of
the major histocompatibility complex (HLA) were also differen-
tially expressed among individuals[2,3], although the specific
genes we identified differed from those previously reported. In our
analysis, 86 cis-SNP genotypes were significantly associated with
the expression of the 20 genes whose expression was concordant
between two independent tissue types. Of these 86 SNPs, a high
proportion (26/86 or 30%) was also significantly associated with
inter-individual variation in gene expression in a prior interroga-
tion of the HapMap cell lines[14].
Of the 20 genes with cis-SNP genotypes significantly associated
with multiple tissue gene expression and that were confirmed in
our first and second validation sets, one gene (DDX17) overlaps
with those reported by Morley et al. as having strong cis-acting
regulators (p,10
29)[9]. From a genome-wide scan, these authors
noted 8 genes whose inter-individual variation in expression was
strongly related to cis genetic variation in CEU lymphoblastoid cell
lines; remarkably, 2 out of the 8 genes with strong cis-acting
regulation were contained within our 20 genes.
The genes we observed whose expression is concordant between
two discrete tissues within the same individual are involved in
several cellular pathways and processes. Genes in overrepresented
pathways include those involved in ubiquitously important cellular
functions, including protein synthesis (RPS12, RPS4Y1 and
RPL36AL) and purine metabolism (GART, XDH, CANT1 and
ADSS). RPS12 and RPS4Y1 are components of the 40S subunit of
the ribosome, while RPL36AL is a component of the 60S subunit,
functioning together in the cytoplasm to catalyze protein synthesis.
We found that the 86 cis-SNPs associated with the expression of
the 20 genes whose expression was concordant between tissues
tended to be flanked by three DNA motifs that were overrepre-
sented compared to those genes whose expression was not
concordant and yet had cis-SNPs affecting their expression.
However, there was no correlation between the expression of
these 20 genes with each other within leukemia cells or within
normal leukocytes, consistent with the fact that these 3 motifs are
not known to represent the expression of DNA regulatory regions.
This suggests that there may be an as yet unknown regulator of
these genes.
Germline genetic polymorphisms may exert their effects on
clinically important phenotypes via multiple mechanisms, only a
fraction of which are related to their effects on transcript
levels[31]. Some of these effects will be tissue specific (e.g.
cytochrome P450 expression in liver) and others will have broad
tissue distribution (e.g. thiopurine methyltransferase in liver,
kidney, brain, leukemia cells, and erythrocytes)[32,33]. Herein,
using commonalities in expression between tissue types and
evidence of cis regulation, we have identified a subset of genes
whose expression is highly related to germline variation in multiple
tissues.
Materials and Methods
Study Population
The discovery set consisted of 92 patients with newly diagnosed
childhood acute lymphoblastic leukemia (ALL) enrolled on St.
Jude Children’s Research Hospital treatment protocol Total XV,
who had both diagnostic leukemia cells and normal peripheral
blood leukocytes available for expression array analysis. The
Institutional Review Board at St. Jude Children’s Research
Hospital approved the investigation, and signed informed consent
was obtained from patients or parents before enrollment, as
appropriate. Samples were obtained at protocol-defined points;
initial samples were obtained from diagnostic leukemia cells prior
to the start of induction chemotherapy. After completion of 7
weeks of remission induction chemotherapy, but prior to
beginning the consolidation phase of chemotherapy, a second
sample was obtained, composed of unsorted normal peripheral
blood leukocytes[34]. 82 of these 92 patients also had germline
DNA samples available for genotyping analysis.
The first validation set comprised an additional 134 patients with
newly diagnosed childhood ALL enrolled on St. Jude treatment
protocols Total XIIIB and XV, with both diagnostic leukemia cell
gene expression and germline SNP data available. The second
validation set comprised lymphoblastoid cell lines derived from 60
unrelated Utah residents with ancestry from northern and Western
Europe (CEU) and from 60 unrelated individuals from Yoruba in
Ibadan, Nigeria (YRI) (www.hapmap.org).
Gene expression profiling
We extracted RNA from diagnostic leukemia cells and normal
peripheral blood leukocytes, assessed its integrity, generated
labeled cRNA and analyzed the samples on the Affymetrix HG-
U133A ArraysH as described[22]. The data were analyzed with
Bioconductor 2.1 using the Affymetrix MAS5.0 algorithm (www.
biocoductor.org). SNPs were downloaded from dbSNP build 126
if they were classed as ‘‘by-cluster,’’ ‘‘by-frequency,’’ ‘‘by-2hit-
2allele,’’ or ‘‘by-hapmap[35]. Probes that encompassed any of
these SNPs were excluded from analysis, and remaining probe sets
with fewer than 3 probes were filtered out. Probes sets that may
cross-hybridize with more than one genomic location were also
filtered out[36], leaving 15,119 probe sets (annotated to 11,783
genes) available for further analysis. Gene expression signals were
normalized so that all expression arrays had the same global
average intensity. Gene expression data for CEU and YRI cell
lines using the Affymetrix GeneChipH Human Exon 1.0 ST Array
comprising ,1.4 million probe sets, and using the Illumina
Sentrix Human-6 Expression BeadChip Version 1 comprising
around 14,500 probe sets, were downloaded from the follow-
ing sites: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE7761; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE6536[14,37].
Genotyping
High quality germline DNA was extracted from the normal
leukocytes. A total of 250 ng of DNA was digested separately with
the XbaI and HindIII restriction enzymes and then amplified,
labeled and hybridized to the Affymetrix GeneChipH Human
Mapping 100 K and 500 K Array Sets. The chips were scanned,
cis-SNPs Determine Expression
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implemented in the GTYPE software (http://www.affymetrix.
com/products/software/specific/gtype.affx). SNPs with call rates
of less than 95% in all patients were filtered out, and only SNPs
within 50 Kb of a gene represented on the U133A expression
array were included, leaving 176,561 SNPs for further analysis.
Genotypes for the SNPs represented on the Affymetrix Gene-
ChipH Human Mapping 100 K and 500 K Array Sets of the CEU
and YRI cell lines were downloaded from release 22 on the
International HapMap project website (www.hapmap.org).
Data analysis
Spearman’s rho rank correlation was used to estimate the
correlation in gene expression between diagnostic leukemia cells
and normal leukocytes for each probe set. The false discovery rate
(FDR) was estimated based on the q-value method[38].
Hierarchical clustering was applied to the normalized gene
expression signals of the diagnostic leukemia cells and the normal
leukocytes in order to cluster samples based on the probe sets
whose expression was most highly correlated between these two
tissue types.
The association between the gene expression signal of each
probe set and each cis-SNP in the diagnostic leukemia cells, in the
normal leukocytes, and in the cell lines (independently), was
evaluated based on linear regression using a codominant model.
That is, AA genotypes were coded as 0, AB genotypes were coded
as 1 and BB genotypes were coded as 2 [11]. We adjusted for race
by including race as a covariate in the regression model.
We first computed the observed p-values for the association for
each SNP genotype and the gene expression for the number of
SNPs (N) within that particular gene. In order to account for the
multiple testing problem caused by multiple SNPs within a gene, we
performed 5,000 permutations, by randomly permuting the gene
expression valuesand recomputingthe association p-valuesbetween
each SNP and the gene expression level. For each permutation, we
recorded the minimum permuted p-value among the N permuted
p-values for a gene and compared the observed p-values to the
minimum p-value obtained from the permutation to adjust for
multiple testing. The adjusted p-value for each SNP is the
percentage of permutations with the observed p-value $ the
minimum permuted p-value and takes into account the different
number of SNPs per gene. This procedure was utilized for all
analyses reported herein (adjusted p,0.05) [39]. There was no
difference in the number of cis-SNPs per gene in the 20 genes whose
expression was concordant between tissues and that had cis-SNPs
associated with their expression, compared to the number of cis-
SNPs per gene for all of the genes (n=8853) that were expressed in
both the leukemia cells and the normal leukocytes (Figure S10).
In our validation analysis, we determined the cis-SNPs that were
associated with the expression of a gene independently in the
diagnostic leukemia cells (validation set 1) and cell lines (validation
set 2). We then looked for overlap in the cis-SNP/genes in these
validation sets with our discovery population by matching the cis-
SNP/gene pairs with adjusted p,0.05.
Bioinformatics
We queried the Database for Annotation, Visualization and
Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov) to
assess the function and pathways of the 176 genes whose
expression was concordant between tissues, the 20 genes of these
176 that had cis-SNPs significantly associated with their expression
and the 1574 genes whose expression was not concordant between
these tissues, but that had cis-SNPs predicting their expression in
the normal leukocytes and the diagnostic leukemia cell samples
from the discovery set and from the validation set (Figure 2b) [40].
We retrieved the 100 bp flanking sequences for each of the cis-
SNPs using BioMart (http://www.biomart.org/), and masked
repetitive DNA elements using the RepeatMask program (http://
repeatmasker.org/cgi-bin/WEBRepeatMasker). Using MEME
(Multiple Em for Motif Elicitation; http://meme.sdsc.edu/), we
searched for repeated sequence patterns, or motifs, that occurred
in these DNA sequences [41]. To search for these motifs in other
cis-SNP sequences, we used MAST (Motif Alignment and Search
Tool), a companion tool of MEME. We used TRANSFACH (the
gene transcription factor database) to determine if any of the
common flanking motifs were known cis-o rtrans-acting regulatory
DNA elements.
Supporting Information
Table S1 176 genes (204 probe sets) whose expression was
concordant between diagnostic leukemia cells and normal
leukocytes (p,0.008).
Found at: doi:10.1371/journal.pone.0002144.s001 (0.37 MB
DOC)
Table S2 31 ‘‘housekeeping genes’’ whose expression is
concordant between diagnostic leukemia cells and normal
peripheral blood leukocytes
Found at: doi:10.1371/journal.pone.0002144.s002 (0.07 MB
DOC)
Table S3 Using MEME, 3 DNA sequence motifs were found to
be overrepresented in the 20 genes whose expression was
concordant between leukemia cells and normal leukocytes and
that had cis-SNPs associated with their expression. These motifs
were also found in the genes in the leukemia cells (green shading)
and normal leukocytes (yellow shading) that had cis-SNPs
associated with their expression, but whose expression was not
concordant in these two tissues. None of the motifs are known
transcription factor binding sites.
Found at: doi:10.1371/journal.pone.0002144.s003 (0.03 MB
DOC)
Figure S1 Unsupervised hierarchical clustering of gene expres-
sion for 184 samples (columns) from 92 patients indicates two
distinct clusters which segregate the different tissue types:
diagnostic leukemia cells and normal leukocytes. (Blood: normal
leukocyte samples; BH: B-lineage ALL with hyperdiploid karyo-
type; BN: B-lineage ALL with non-hyperdiploid karyotype; bcr:
BCR-ABL translocation; e2a: E2A-PBX translocation; mll: MLL-
AF4 fusion; other: B-lineage ALL with no defined translocations;
tel: TEL-AML1 translocation; T: T-lineage ALL).
Found at: doi:10.1371/journal.pone.0002144.s004 (0.05 MB
DOC)
Figure S2 Each circle represents a probe set. The average
expression of each probe set in diagnostic leukemia cells for the 92
patients is shown on the x-axis and for normal leukocytes is shown
on the y-axis. The line of identity shows comparable expression
levels in both cell types. The blue circles indicate the 204 probe
sets whose expression was concordant between the diagnostic
leukemia cells and the normal leukocytes. The red circles indicate
the 21 of these 204 probe sets that had cis-SNPs predicting their
expression. The grey circles are the remaining 14,915 probe sets.
The closer the circles are to the line of identity, the more similar
the level of expression of that probe set in both tissues. The dotted
line indicates a log2 expression level of 8, indicating that the 21
probe sets with cis-SNPs predicting their expression is higher than
cis-SNPs Determine Expression
PLoS ONE | www.plosone.org 8 May 2008 | Volume 3 | Issue 5 | e2144the overall expression of the 204 probe sets whose expression is
concordant between tissue types.
Found at: doi:10.1371/journal.pone.0002144.s005 (2.06 MB
DOC)
Figure S3 a) Histogram showing the number of probe sets (y-
axis) whose expression was correlated between tissue types at
specific p-value cut offs (x-axis). The histogram indicates a
significant correlation between gene expression in diagnostic
leukemia cells and normal leukocytes as shown by an over-
representation of probe sets with low p-values. A positive
correlation of gene expression between diagnostic leukemia cells
and normal leukocytes is shown by white shading and a negative
correlation is shown by grey shading. The figure indicates a
significantly higher number of probe sets than expected are
positively correlated between diagnostic leukemia cells and normal
leukocytes. b) Hierarchical clustering of gene expression with each
column representing one of the 184 patient samples (92 leukemia
cell and 92 normal leukocyte samples) and each row representing
one of the top 136 probe sets (ordered by p-value; p,0.0048 cut-
off) that are positively correlated between the diagnostic leukemia
cells and normal leukocytes. Using these 136 probe sets, 55 out of
the 92 patient sample pairs were clustered together as indicated
with blue dashes below the clustering. Green=low expression and
red=high expression.
Found at: doi:10.1371/journal.pone.0002144.s006 (0.12 MB
DOC)
Figure S4 a) Examples of genes (here ADI1, PEX6, AMFR,
ZNF266 and SAR1A) whose expression was concordant between
diagnostic leukemia cells and normal leukocytes: Left: expression
levels among 92 patients in leukemia cells and normal leukocytes
are correlated (p=0.0025, ,0.00001, 1.4461028, 0.0038,
,0.00001 respectively); Middle: expression of these genes
(median, quantiles, range) in leukemia cells was associated
(adjusted p=0.0016, 0.0006, 0.0002, 0.0004, 0.001 respectively)
with the germline genotype of a particular cis-SNP in this gene;
Right: expression of these genes in normal leukocytes was associated
(adjusted p=0.0072, 0.0006, 0.0014, 0.0004, 0.0208 respectively)
with the germline genotype at the same cis-SNP. b) Examples of
genes (here NRG1, NCOA1, C20orf23, C9orf39, ATM) whose
expression was not concordant between diagnostic leukemia cells
and normal leukocytes: Left: expression levels among 92 patients in
leukemia cells and normal leukocytes was not concordant
(p=0.9799, 0.9377, 0.9523, 0.9128, 0.9607 respectively); Middle:
expression of these genes in leukemia cells was not associated
(adjusted p=0.9996, 0.080,1.000, 0.5106, 0.9996respectively) with
the germline genotype of a particular cis-SNP in this gene; Right:
expression of these genes in normal leukocytes was not associated
(adjusted p=1.000, 1.000, 1.000, 0.9982, 0.9320 respectively) with
the germline genotype at the same cis-SNP.
Found at: doi:10.1371/journal.pone.0002144.s007 (0.20 MB
DOC)
Figure S5 a) At adjusted p,0.05, there was no difference in the
number of cis-SNPs associated with the expression of the 176
concordant genes in the normal leukocytes and the leukemia cells
that constituted our discovery set. 133 of these 176 concordantly
expressed genes are represented on the Exon Array for the
HapMap cell lines that constituted one validation set. There was
no significant difference between the number of cis-SNPs
associated with the expression of these 133 genes in the HapMap
cell lines (validation set) compared to the number of cis-SNPs
associated with expression of the 176 genes in the normal
leukocytes (p=0.34, Fishers exact test) or the diagnostic leukemia
cells (p=0.34, Fishers exact test). Specifically, in the normal
leukocytes (yellow circle), there are 30 genes with significant cis-
SNPs; in the leukemia cells (green circle), there are 30 genes with
significant cis-SNPs; and in the HapMap cell lines (pink circle),
there are 17 genes with significant cis-SNPs, focusing on the genes
whose expression was concordant between leukemia cells and
normal leukocytes. There are 8 out of 176 genes (centre of VENN
diagram) with significant cis-SNPs that are common to all 3 sets
representing 4.5%* of the 176 genes. b) At adjusted p,0.05, there
was no difference in the number of cis-SNPs associated with the
expression of the 8,853 expressed genes in the normal leukocytes
and the leukemia cells that constituted one discovery set. 8,187 of
the 8,853 expressed genes are represented on the Exon Array for
the HapMap cell lines that constituted our validation set. There
was a significant difference between the number of cis-SNPs
associated with the expression of these 8,187 genes in the HapMap
cell lines (validation set) compared to the number of cis-SNPs
associated with expression of the 8,853 genes in the normal
leukocytes (p=1.30610211, Fishers exact test) and the diagnostic
leukemia cells (p=3.00610214, Fishers exact test). Specifically, in
the normal leukocytes (yellow circle), there are 559 genes with
significant cis-SNPs; in the leukemia cells (green circle), there are
532 genes with significant cis-SNPs; and in the HapMap cell lines
(pink circle), there are 743 genes with significant cis-SNPs, whose
expression was not concordant between tissues. There are 15 out
of 8,853 genes (center of VENN diagram) with significant cis-SNPs
common to all 3 sets representing 0.17%* of the 8,853 genes.
Found at: doi:10.1371/journal.pone.0002144.s008 (1.46 MB
DOC)
Figure S6 Results of pathway analysis of genes whose expression
was concordant between leukemia cells and normal leukocytes and
had cis-SNPs associated with their expression in the discovery set
(n=20) compared to those genes that are expressed, but not
concordantly expressed in the two tissues and have cis-SNPs
associated with their expression (n=1574), as determined by
interrogating the Database for Annotation, Visualization and
Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/).
None of the pathways reached statistical significance using this
tool.
Found at: doi:10.1371/journal.pone.0002144.s009 (0.08 MB
DOC)
Figure S7 Results of pathway analysis of genes whose expression
was concordant between leukemia cells and normal leukocytes in
the discovery set and had cis-SNPs affecting their expression
(n=20) to over represent specific pathways compared to those
genes that did not have cis-SNPs associated with their expression
(n=156) as determined by interrogating DAVID. Genes involved
in the tryptophan metabolism pathway were marginally signifi-
cantly over represented using this tool (p=0.05, Fishers exact test).
Found at: doi:10.1371/journal.pone.0002144.s010 (0.07 MB
DOC)
Figure S8 There was no strong correlation (p.0.05, Pearson’s
correlation) in the diagnostic leukemia cells of expression between
the 20 cis-SNP genes whose expression is concordant between
diagnostic leukemia cells and normal leukocytes. Yellow indicates
a strong positive correlation and increasing blue indicates no
strong positive correlation.
Found at: doi:10.1371/journal.pone.0002144.s011 (0.10 MB
DOC)
Figure S9 There was no strong correlation (p.0.05, Pearson’s
correlation) in the normal leukocytes of expression between the 20
cis-SNP genes whose expression is concordant between diagnostic
leukemia cells and normal leukocytes. Yellow indicates a strong
cis-SNPs Determine Expression
PLoS ONE | www.plosone.org 9 May 2008 | Volume 3 | Issue 5 | e2144positive correlation and increasing blue indicates no strong positive
correlation.
Found at: doi:10.1371/journal.pone.0002144.s012 (0.10 MB
DOC)
Figure S10 There was no significant difference between the
number of cis-SNPs per gene in the 20 genes whose expression was
concordant between tissue types and that had cis-SNPs associated
with their expression and the 8,853 genes whose expression was
not concordant (p=0.769, Wilcoxon test).
Found at: doi:10.1371/journal.pone.0002144.s013 (0.06 MB
DOC)
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